NO934851L - Fremgangsmåte for stimulering av immunrespons - Google Patents

Fremgangsmåte for stimulering av immunrespons

Info

Publication number
NO934851L
NO934851L NO934851A NO934851A NO934851L NO 934851 L NO934851 L NO 934851L NO 934851 A NO934851 A NO 934851A NO 934851 A NO934851 A NO 934851A NO 934851 L NO934851 L NO 934851L
Authority
NO
Norway
Prior art keywords
immune response
igf
stimulating immune
stimulating
bird
Prior art date
Application number
NO934851A
Other languages
English (en)
Norwegian (no)
Other versions
NO934851D0 (no
Inventor
Ross G Clark
Paula M Jardieu
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO934851D0 publication Critical patent/NO934851D0/no
Publication of NO934851L publication Critical patent/NO934851L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/30—Insulin-like growth factors, i.e. somatomedins, e.g. IGF-1, IGF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO934851A 1991-06-28 1993-12-27 Fremgangsmåte for stimulering av immunrespons NO934851L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/722,813 US5202119A (en) 1991-06-28 1991-06-28 Method of stimulating immune response
PCT/US1992/005189 WO1993000110A1 (fr) 1991-06-28 1992-06-16 Procede de stimulation de la reponse immunitaire

Publications (2)

Publication Number Publication Date
NO934851D0 NO934851D0 (no) 1993-12-27
NO934851L true NO934851L (no) 1994-02-25

Family

ID=24903495

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934851A NO934851L (no) 1991-06-28 1993-12-27 Fremgangsmåte for stimulering av immunrespons

Country Status (14)

Country Link
US (2) US5202119A (fr)
EP (1) EP0602050B1 (fr)
JP (1) JPH06508830A (fr)
AT (1) ATE152627T1 (fr)
AU (1) AU655059B2 (fr)
CA (1) CA2109705A1 (fr)
DE (1) DE69219607T2 (fr)
DK (1) DK0602050T3 (fr)
ES (1) ES2101106T3 (fr)
FI (1) FI935898A0 (fr)
GR (1) GR3024128T3 (fr)
NO (1) NO934851L (fr)
NZ (1) NZ243232A (fr)
WO (1) WO1993000110A1 (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97779A (en) * 1990-04-10 2000-01-31 Genentech Inc Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
US5744139A (en) * 1991-06-28 1998-04-28 University Of Tennessee Research Corporation Insulin-like growth factor I (IGF-1) induced improvement of depressed T4/T8 ratios
CA2132871A1 (fr) * 1993-01-25 1994-08-04 Alan C. Moses Methode de modification, de diagnostic et de detection du pouvoir de resistance des cellules sensible au facteur de croissance insulinoide i
WO1994021279A1 (fr) * 1993-03-19 1994-09-29 Rothkopf Michael M Formulations nutritives et procedes permettant de traiter la malnutrition des sideens
GB9310049D0 (en) * 1993-05-12 1993-06-30 Cancer Res Campaign Tech Growth factor effects
DE69434403T2 (de) * 1993-09-20 2006-05-04 Celtrix Pharmaceuticals, Inc. Behandlung von immunologischen und hämatologischen Störungen mit IGFBP allein oder als Komplex mit IGF
US5661122A (en) * 1994-04-15 1997-08-26 Genentech, Inc. Treatment of congestive heart failure
US5610134A (en) * 1994-04-15 1997-03-11 Genentech, Inc. Treatment of congestive heart failure
SE9402370D0 (sv) * 1994-07-04 1994-07-04 Pharmacia Ab Use of IGF-I
AUPM678294A0 (en) * 1994-07-13 1994-08-04 Gropep Pty Ltd Use of insulin-like growth factor in combination with insulin
US5565428A (en) * 1995-05-22 1996-10-15 Genentech, Inc. Method of administration of IGF-I
US5741776A (en) * 1995-05-22 1998-04-21 Genentech, Inc. Method of administration of IGF-I
US5948757A (en) * 1996-03-01 1999-09-07 Celtrix Pharmaceuticals, Inc. High dose IGF-1 therapy
US5783556A (en) * 1996-08-13 1998-07-21 Genentech, Inc. Formulated insulin-containing composition
US6210697B1 (en) * 1996-10-16 2001-04-03 Sumitomo Pharmaceuticals Company, Limited Medicament for hypothermia treatment
US6015786A (en) * 1997-02-25 2000-01-18 Celtrix Pharmaceuticals, Inc. Method for increasing sex steroid levels using IGF or IGF/IGFBP-3
US6514937B1 (en) 1997-02-25 2003-02-04 Celtrix Pharmaceuticals, Inc. Method of treating psychological and metabolic disorders using IGF or IGF/IGFBP-3
US6025368A (en) * 1997-02-25 2000-02-15 Celtrix Pharmaceuticals, Inc. Method for treating the symptoms of chronic stress-related disorders using IGF
US6121416A (en) 1997-04-04 2000-09-19 Genentech, Inc. Insulin-like growth factor agonist molecules
US6420518B1 (en) 1997-04-04 2002-07-16 Genetech, Inc. Insulin-like growth factor agonist molecules
EP1016414B1 (fr) * 1998-12-17 2004-09-08 Applied Research Systems ARS Holding N.V. Utilisation de l'hormone de croissance pour stimuler l'hématopoièse et la reconstitution immunitaire après la transplantation de cellules hématopoiétiques chez les humains
AU762351B2 (en) * 1999-01-06 2003-06-26 Genentech Inc. Insulin-like growth factor (IGF) I mutant variants
AT408721B (de) 1999-10-01 2002-02-25 Cistem Biotechnologies Gmbh Pharmazeutische zusammensetzung enthaltend ein antigen
AU2001246393A1 (en) * 2000-03-31 2001-10-08 Vaccine Chip Technology Aps Immunostimulating properties of a fragment of tgf-beta
US20030190322A1 (en) * 2000-03-31 2003-10-09 Peter Kaastrup Immunostimulating properties of a fragment of tgf-beta
ATE389416T1 (de) * 2000-05-16 2008-04-15 Genentech Inc Behandlung von knorpelerkrankungen
CN100439397C (zh) * 2001-02-09 2008-12-03 基因技术股份有限公司 Igf-1的结晶
US7326417B2 (en) * 2001-09-11 2008-02-05 Merial Ltd. IGF-1 as feline vaccine adjuvant, in particular against feline retroviruses
FR2829498B1 (fr) * 2001-09-11 2003-11-28 Merial Sas Igf-1 comme adjuvant de vaccin felin, notamment contre les retrovirus felins
JP2008511838A (ja) * 2004-08-30 2008-04-17 テルシカ・インク インシュリン様成長因子欠乏疾患の診断及び治療のための方法及び装置

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189426A (en) * 1976-04-12 1980-02-19 Hoffmann-La Roche, Inc. Recombinant hormonal compositions and method
US4898830A (en) * 1979-07-05 1990-02-06 Genentech, Inc. Human growth hormone DNA
US4342832A (en) * 1979-07-05 1982-08-03 Genentech, Inc. Method of constructing a replicable cloning vehicle having quasi-synthetic genes
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
US4446235A (en) * 1982-03-22 1984-05-01 Genentech, Inc. Method for cloning human growth hormone varient genes
US4859600A (en) * 1983-04-25 1989-08-22 Genentech, Inc. Recombinant procaryotic cell containing correctly processed human growth hormone
US4755465A (en) * 1983-04-25 1988-07-05 Genentech, Inc. Secretion of correctly processed human growth hormone in E. coli and Pseudomonas
US4791099A (en) * 1984-10-29 1988-12-13 Chaovanee Aroonsakul Method of treatment for central nervous system diseases such as Alzheimer's's disease
ATE81779T1 (de) * 1985-08-22 1992-11-15 Gropep Pty Ltd Peptidanalogedes insulinaehnlichen wachstumsfaktors-1 bei saeugetieren.
US4863901A (en) * 1986-01-09 1989-09-05 Brigham & Women's Hospital Use of growth hormone for nitrogen retention under hypocaloric conditions
US4769361A (en) * 1986-08-07 1988-09-06 International Minerals & Chemical Corp. Method for purifying and isolating two ionic forms of somatomedin C
US4816439A (en) * 1987-03-27 1989-03-28 Nordiske Gentofte A/S The use of human growth hormone for the treatment of intoxicated individuals
US4833166A (en) * 1987-05-01 1989-05-23 Grosvenor Clark E Growth hormone releasing hormone complementary peptides
US5028591A (en) * 1987-09-14 1991-07-02 Pitman-Moore, Inc. Method for stimulating the immune system
US4837202A (en) * 1987-09-14 1989-06-06 Pitman-Moore, Inc. Method for stimulating the immune system
ATE116335T1 (de) * 1987-12-24 1995-01-15 Gropep Pty Ltd Peptid-analoge vom insulinähnlichen wachstums- faktor 1 (igf-1) oder faktor 2 (igf-2).
US4939124A (en) * 1988-01-26 1990-07-03 Laboratorios Serono S.A. Treatment and diagnosis of dementia
GB8821656D0 (en) * 1988-09-15 1988-10-12 Health Lab Service Board Pharmaceutical compositions for eliciting immunostimulant effect
NZ236618A (en) * 1990-01-03 1997-06-24 Ciba Geigy Ag Treating and preventing osteoporosis using insulin-like growth factor i (igf i) in conjunction with a bone antiresorptive active compound
US5202119A (en) * 1991-06-28 1993-04-13 Genentech, Inc. Method of stimulating immune response
US5317012A (en) * 1991-10-04 1994-05-31 The University Of Tennessee Research Corporation Human growth hormone induced improvement in depressed T4/T8 ratio

Also Published As

Publication number Publication date
ES2101106T3 (es) 1997-07-01
AU2252592A (en) 1993-01-25
CA2109705A1 (fr) 1993-01-07
JPH06508830A (ja) 1994-10-06
NO934851D0 (no) 1993-12-27
WO1993000110A1 (fr) 1993-01-07
DE69219607T2 (de) 1997-09-04
FI935898L (fi) 1993-12-28
EP0602050A1 (fr) 1994-06-22
DK0602050T3 (da) 1997-06-02
FI935898A7 (fi) 1993-12-28
NZ243232A (en) 1997-07-27
ATE152627T1 (de) 1997-05-15
AU655059B2 (en) 1994-12-01
US5583109A (en) 1996-12-10
EP0602050B1 (fr) 1997-05-07
GR3024128T3 (en) 1997-10-31
DE69219607D1 (de) 1997-06-12
FI935898A0 (fi) 1993-12-28
US5202119A (en) 1993-04-13

Similar Documents

Publication Publication Date Title
NO934851L (no) Fremgangsmåte for stimulering av immunrespons
ATE135587T1 (de) Kombination von igf-i und igfbp für den aufbaustoffwechsel (anabolismus)
ATE160787T1 (de) Verfahren zur herstellung von hefe-glucanen
DE69120890D1 (de) Menschliches lymph-gewebe in einem wirt mit angegriffenem immunsystem
ES2112860T3 (es) Inmunoterapia adoptiva con interleukina-7.
DK641889D0 (da) Anvendelse af en blodpladeaktiveringsfaktorantagonist i kombination med monoklonale eller polyklonale antistoffer i et farmaceutisk praeparat til behandling af endotoksisk chok hos pattedyr
ATE82507T1 (de) Medizinische verwendung.
DE3482907D1 (de) Verwendung des diterpen-derivates forskolin zur immunstimulation.
ES2124257T3 (es) Composicion, metodo y equipo para la estimulacion de la actividad antitumoral y para el tratamiento de tumores.
NO940180L (no) Anvendelse av IGF-I
IL106948A0 (en) Method of administering igf-1,igf-2 and analogs thereof to birds
NO870123L (no) Mastittvaksine.
Harvey et al. Serum concentrations of prolactin, luteinizing hormone, growth hormone, corticosterone, progesterone, testosterone and oestradiol in relation to broodiness in domestic turkeys (Meleagris gallopavo)
DK162880C (da) Fremgangsmaade til behandling af acycli hos faar og kvaeg, og anvendelse af gestagener og lh-rh eller dettes analoge ved behandling af acycli hos faar og kvaeg
EP0254845A3 (fr) Stimulation d'immunité avec le chondroitine sulfate
ATE98129T1 (de) Somatotropin zur steigerung der fertilitaet bei tieren.
DE68928646D1 (de) Natriuretisches hormon
DK0586592T3 (da) Insulin- og amylinholdig sammensætning til behandling af insulindeficiente pattedyr
EP0308717A3 (en) Method of treating viral encephalitis
DE69021210D1 (de) Vogel-Interleukin-2 zur Wachstumssteigerung von Vögeln.
ZA922421B (en) Stimulation of growth with anti-idiotypic antibodies raised against an antibody to a growth potentiating polypeptide
HK35793A (en) Increasing endogenous growth hormone
DURING et al. Moscow DOKLADY AKADEMII NAUK SSSR In Russian Vol 275, No 2, Mar 84 (manuscript received 2 Nov 83) pp 506-509 KASSIL', GN, LEVANDO, V, A., SUZDAL'NITSKIY, RS, PERSHIN, BB and
KR890008879U (ko) 샷틀직기에 있어서 바디고정용 플라이백(fly back)